Toward an oligonucleotide therapy for Duchenne muscular dystrophy: a complex development challenge.

Antisense oligonucleotide (AO)-mediated exon skipping is a promising new therapy for Duchenne muscular dystrophy (DMD), recently demonstrating proof of principle for restoring the absent dystrophin protein in DMD patients. However, the range of AO chemistries available for exon skipping is limited;...

全面介绍

书目详细资料
主要作者: Wood, M
格式: Journal article
语言:English
出版: 2010

相似书籍